Daytime Nighttime Sinus Relief Kit
NDC Package 11673-282-09
Package Information
Daytime Nighttime Sinus Relief (acetaminophen, diphenhydramine hcl, guaifenesin, phenylephrine hcl) kits is do not take more than directeddo not take more than 12 caplets in any 24-hour periodadults and children 12 years and over: take 2 caplets every 4 hourschildren under 12 years: do not use. This formulation utilizes a kit delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-282 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1233575 - acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet
- RxCUI: 1233575 - acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI: 1233575 - acetaminophen 325 MG / diphenhydramine HCl 12.5 MG / phenylephrine HCl 5 MG Oral Tablet
- RxCUI: 1233575 - APAP 325 MG / Diphenhydramine Hydrochloride 12.5 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet
- RxCUI: 1243679 - acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11673 - Target Corporation
- 11673-282 - Daytime Nighttime Sinus Relief
- 11673-282-09 - 1 KIT in 1 CARTON * 12 TABLET, FILM COATED in 1 BLISTER PACK * 8 TABLET, FILM COATED in 1 BLISTER PACK
- 11673-282 - Daytime Nighttime Sinus Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11673-282-09 identifies a specific commercial package of 1 kit in 1 carton * 12 tablet, film coated in 1 blister pack * 8 tablet, film coated in 1 blister pack of Daytime Nighttime Sinus Relief, a human over the counter drug labeled by Target Corporation. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on April 15, 2024.
How is this Target Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673028209. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.